跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 102 条关于
“Invagen”
全部
102
临床试验
48
药物
28
机构
16
资讯
10
2个月前
USFDA Classifies Cipla's InvaGen New York Unit 3 Inspection as Voluntary Action Indicated
19天前
Cipla Secures Exclusive Rights to HER2 Bispecific ADC TQB2102 Across Seven Emerging Markets
12个月前
Federal Circuit Rules "Clinically Proven Effective" Claims Cannot Rescue Anticipated Drug Methods from Prior Art
去年
Innogen Seeks $100 Million Hong Kong IPO to Advance GLP-1 Pipeline
9个月前
Niagen Bioscience Acquires Core NAD+ Patent Portfolio from Queen's University Belfast
去年
Innogen Pharmaceutical Soars 296% in Hong Kong Debut Following GLP-1 Diabetes Drug Approval
去年
Niagen Bioscience Secures Exclusive License for Nicotinamide Riboside as Parkinson's Disease Therapy
去年
Former Poseida CEO Kristin Yarema Named to Lead Ikena-Inmagene Merger as Companies Advance Anti-OX40 Therapy
去年
Inmagene Initiates Phase 2b Trial of IMG-007 Anti-OX40 Antibody for Moderate-to-Severe Atopic Dermatitis
2个月前
Niagen Bioscience Launches NB4168, a Proprietary NAD+ Precursor, as First Pharmaceutical Candidate for Ataxia Telangiectasia